Please use a PC Browser to access Register-Tadawul
Get It
Anavex Life Sciences's Earnings Outlook
Anavex Life Sciences Corp. 0.00%
Anavex Life Sciences Corp. AVXL | 4.65 | 0.00% |
Anavex Life Sciences (NASDAQ:AVXL) is gearing up to announce its quarterly earnings on Monday, 2026-02-09. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Anavex Life Sciences will report an earnings per share (EPS) of $-0.11.
The market awaits Anavex Life Sciences's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
Overview of Past Earnings
The company's EPS beat by $0.03 in the last quarter, leading to a 11.56% increase in the share price on the following day.
Here's a look at Anavex Life Sciences's past performance and the resulting price change:
| Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| EPS Estimate | -0.14 | -0.14 | -0.15 | -0.17 |
| EPS Actual | -0.11 | -0.16 | -0.13 | -0.14 |
| Price Change % | 12.00 | -2.00 | 1.00 | -3.00 |
Anavex Life Sciences Share Price Analysis
Shares of Anavex Life Sciences were trading at $3.81 as of February 05. Over the last 52-week period, shares are down 53.29%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.
To track all earnings releases for Anavex Life Sciences visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
